Catalyst
Slingshot members are tracking this event:
AcelRx (ACRX) Announces Phase III Results for ARX-04 in Treatment of Moderate-to-Severe Acute Pain
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ACRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 15, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Moderate-to-severe Acute Pain, Sap303, Arx-04
